Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board consists of executive, non-executive, and independent non-executive directors, with various members serving on four key committees: Audit, Remuneration and Review, Nomination, and Strategy and Sustainable Development. This announcement underscores the company’s commitment to structured governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biotechnology industry. It focuses on developing and manufacturing biological products, though specific products or market focus are not detailed in the release.
Average Trading Volume: 698,022
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.93B
Learn more about 6826 stock on TipRanks’ Stock Analysis page.